Application

Anti-TMEM16A, clone 3J18 ZooMAb , Cat. No. ZRB1171, is a highly specific recombinant rabbit monoclonal antibody that detects Transmembrane protein 16A (TMEM16A) and has been tested for use in Immunofluorescence, Immunohistochemistry (Paraffin), and Western Blotting.

Western Blotting Analysis: A 1:100 dilution from a representative lot detected TMEM16A in human pancreas tissue lysate.Immunofluorescence Analysis: A 1:100 dilution from a representative lot detected TMEM16A in human salivary gland tissue sections.Note: Actual optimal working dilutions must be determined by the end user as specimens and experimental conditions may vary.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.

Immunogen

KLH-conjugated linear peptide corresponding to 15 amino acids from the extracellular C-terminal region of human Transmembrane protein 16A (TMEM16A).

Legal Information

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

Physical form

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose. Normal appearance is a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.

Reconstitution

300 µg/mL after reconstitution at 25 µL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Specificity

Clone 3J18 is a ZooMAb rabbit recombinant monoclonal antibody that specifically detects human Transmembrane protein 16A (TMEM16A). It targets an epitope within 15 amino acids from the extracellular domain from the C-terminal half.

Storage and Stability

Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 µL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.

Target description

Transmembrane protein 16A (UniProt: Q5XXA6; also known as TMEM16A, Anoctamin-1, Discovered on gastrointestinal stromal tumors protein 1, Oral cancer overexpressed protein 2, Tumor-amplified and overexpressed sequence 2) is encoded by the ANO1 (also known as DOG1, ORAOV2, TAOS2, TMEM16A) gene (Gene ID: 55107) in human. TMEM16A is a homodimeric multi-pass membrane protein that along with TMEMB16B subunit serves as the calcium-activated chloride channels (CaCC). It is broadly expressed with higher levels in liver, skeletal muscle, and gastrointestinal muscles. It plays a role in transepithelial anion transport and smooth muscle contraction and is also required for the normal functioning of the interstitial cells of Cajal (ICCs) that generate electrical pacemaker activity in gastrointestinal smooth muscles. It also acts as a major contributor to basal and stimulated chloride conductance in airway epithelial cells and plays an important role in tracheal cartilage development. ATP and calmodulin are shown to be essential for TMEM16A activation and the channel activity is inhibited by CFTR protein and by chloride channel inhibitors such as niflumic acid and 4, 4 -diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS). This ZooMAb recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals.